Genzyme, Isis: Cholesterol Drug Meets Goals In Fourth Late-stage Trial - UpdateInformation on Genzyme, Isis: Cholesterol Drug Meets Goals In Fourth Late-stage Trial - Update under Cholesterol section of the Health Articles & Reviews; Genzyme Corp. (GENZ) and Isis Pharmaceuticals Inc. (ISIS) reported Wednesday that their investigational cholesterol-reducing drug Mipomersen met all study goals in a late-stage trial in ... |
![]() |
|
Genzyme, Isis: Cholesterol Drug Meets Goals In Fourth Late-stage Trial - Update
by Eric_Allert 09-01-2010, 01:56 PM
Genzyme Corp. (GENZ) and Isis Pharmaceuticals Inc. (ISIS) reported Wednesday that their investigational cholesterol-reducing drug Mipomersen met all study goals in a late-stage trial in patients with heterozygous familial hypercholesterolemia, or heFH.
More... |
|
Views 3
Comments 0
|
![]() |
| Bookmarks |
| Currently Active Users Viewing This Article: 1 (0 members and 1 guests) | |
| Article Tools | |
| Display Modes | |
|
|
![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() |